Citalopram for major depressive disorder in adults: A systematic review and meta-analysis of published placebo-controlled trials
Apler A. Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials. Br Med J Open. 2011;1:e000106.
Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression
Wand AP. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression. Aust N Z J Psychiatry. 2012;46:178.
Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved?
Schuld A, Archelos JJ, Friess E. Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: is the sigma receptor involved? J Clin Psychopharmacol. 2000;20:579-580.
Mirtazapine plus citalopram has short term but not longer term benefits over citalopram alone for the symptoms of obsessive compulsive disorder
Schuele C, Laakmann G. Mirtazapine plus citalopram has short term but not longer term benefits over citalopram alone for the symptoms of obsessive compulsive disorder. Evid Based Ment Health. 2005;8:42.
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: A pilot study
Pallanti S, Quercoli L, Bruscoli M. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study. J Clin Psychiatry. 2004;65:1394-1399.